You are here

Situation Report

U.S. FDA approves COVID preventive Pemgarda for immunocompromised persons

 

The Food and Drug Administration (FDA) on March 22 granted emergency use authorization (EUA) for Invivyd's monoclonal antibody to prevent COVID-19 in immunocompromised patients, which fills a gap following the withdrawal of Evusheld in January 2023.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

The US is settling into a new approach to respiratory virus season

...

Experts say that focused planning and forecasting efforts helped avoid some of the worst-case scenarios. But there was still a significant number of severe outcomes, and there are still key areas of improvement – especially around vaccination.

...

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Situation Report
howdy folks